• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌的预后因素:对234例连续患者的多因素分析

Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients.

作者信息

Bellantone R, Lombardi C P, Boscherini M, Ferrante A, Raffaelli M, Rubino F, Bossola M, Crucitti F

机构信息

Istituto di Clinica Chirurgica, Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

J Surg Oncol. 1998 Aug;68(4):237-41. doi: 10.1002/(sici)1096-9098(199808)68:4<237::aid-jso6>3.0.co;2-5.

DOI:10.1002/(sici)1096-9098(199808)68:4<237::aid-jso6>3.0.co;2-5
PMID:9721709
Abstract

BACKGROUND AND OBJECTIVES

The clinical characteristics and patient outcome of a group of patients treated for differentiated thyroid carcinoma (DTC) were analyzed in order to assess the relative influence of different prognostic factors.

MATERIALS AND METHODS

We retrospectively reviewed data about sex, age, size and histologic behavior of the tumor, extrathyroid extension of the tumor, lymph node status, distant metastasis at diagnosis, surgical procedures, and overall survival from 234 patients treated for DTC. Data were submitted to a statistical analysis.

RESULTS

Using a univariate analysis, we found that survival rates were significantly influenced by age (P = 0.0001), size (P = 0.018), extrathyroidal extension (P = 0.000001), lymph node involvement (P = 0.03), and distant metastases (P = 0.049). Age and size were independent prognostic factors at multivariate analysis (t = 2.694 and t = 2.443, respectively).

CONCLUSIONS

On the basis of our results and of a review of the literature, we conclude that total thyroidectomy is the treatment of choice in DTC, except for small (<1 cm) papillary carcinoma, that could be treated by lobectomy plus isthmectomy, while lymphadenectomy is indicated only in case of macroscopic involvement.

摘要

背景与目的

分析一组分化型甲状腺癌(DTC)患者的临床特征及预后,以评估不同预后因素的相对影响。

材料与方法

我们回顾性分析了234例接受DTC治疗患者的性别、年龄、肿瘤大小及组织学行为、肿瘤甲状腺外侵犯、淋巴结状态、诊断时的远处转移、手术方式及总生存期等数据。对数据进行统计学分析。

结果

单因素分析显示,生存率受年龄(P = 0.0001)、肿瘤大小(P = 0.018)、甲状腺外侵犯(P = 0.000001)、淋巴结受累(P = 0.03)及远处转移(P = 0.049)的显著影响。多因素分析显示年龄和肿瘤大小是独立的预后因素(分别为t = 2.694和t = 2.443)。

结论

基于我们的研究结果及文献回顾,我们得出结论,除小(<1 cm)乳头状癌可行甲状腺叶切除加峡部切除外,DTC的治疗首选全甲状腺切除术,而仅在有肉眼可见受累时才进行淋巴结清扫。

相似文献

1
Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients.分化型甲状腺癌的预后因素:对234例连续患者的多因素分析
J Surg Oncol. 1998 Aug;68(4):237-41. doi: 10.1002/(sici)1096-9098(199808)68:4<237::aid-jso6>3.0.co;2-5.
2
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.甲状腺乳头状癌区域淋巴结转移的结外扩展的预后意义
Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29.
3
[Surgical treatment and long-term efficacy on stage T1-3N0 differentiated thyroid carcinoma].[T1-3N0期分化型甲状腺癌的手术治疗及长期疗效]
Ai Zheng. 2008 Mar;27(3):299-303.
4
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
5
Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?根据我们自己的风险分组分类系统对甲状腺乳头状癌进行风险适应性管理:甲状腺叶切除术是低风险患者的首选治疗方法吗?
Surgery. 2014 Dec;156(6):1579-88; discussion 1588-9. doi: 10.1016/j.surg.2014.08.060. Epub 2014 Sep 26.
6
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
7
Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.双侧预防性中央区颈淋巴结清扫术后甲状腺乳头状癌的隐匿性淋巴结转移及区域复发风险:一项多机构研究
Surgery. 2017 Feb;161(2):465-471. doi: 10.1016/j.surg.2016.07.031. Epub 2016 Aug 26.
8
Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.影响甲状腺微小乳头状癌颈部淋巴结复发和远处转移的预后因素:445例患者的研究结果
Thyroid. 2009 Jul;19(7):707-16. doi: 10.1089/thy.2008.0270.
9
Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.淋巴结转移的结外侵犯作为乳头状甲状腺癌复发和生存的预后指标。
J Surg Oncol. 2017 Sep;116(4):450-458. doi: 10.1002/jso.24713. Epub 2017 Jun 12.
10
[Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].[分化型甲状腺癌和C细胞癌淋巴结转移对预后的意义——一项荟萃分析]
Zentralbl Chir. 1997;122(4):259-65.

引用本文的文献

1
Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.基于 SEER 计划的研究:分化型甲状腺癌伴远处转移患者生存列线图的建立与验证。
J Endocrinol Invest. 2024 Jan;47(1):115-129. doi: 10.1007/s40618-023-02129-w. Epub 2023 Jun 9.
2
Causal inference between aggressive extrathyroidal extension and survival in papillary thyroid cancer: a propensity score matching and weighting analysis.侵袭性甲状腺外延伸与甲状腺乳头状癌患者生存的因果关系:倾向评分匹配和加权分析。
Front Endocrinol (Lausanne). 2023 May 24;14:1149826. doi: 10.3389/fendo.2023.1149826. eCollection 2023.
3
The role of the size in thyroid cancer risk stratification.
大小在甲状腺癌风险分层中的作用。
Sci Rep. 2021 Mar 31;11(1):7303. doi: 10.1038/s41598-021-86611-6.
4
Innovative analysis of distant metastasis in differentiated thyroid cancer.分化型甲状腺癌远处转移的创新分析
Oncol Lett. 2020 Mar;19(3):1985-1992. doi: 10.3892/ol.2020.11304. Epub 2020 Jan 15.
5
Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.微小与大体临床淋巴结阴性乳头状甲状腺癌中央区颈部淋巴结转移的危险因素
World J Surg. 2018 Mar;42(3):623-629. doi: 10.1007/s00268-017-4390-z.
6
Video-assisted endocrine neck surgery: state of the art.视频辅助颈部内分泌手术:现状
Updates Surg. 2017 Jun;69(2):199-204. doi: 10.1007/s13304-017-0467-3. Epub 2017 Jun 15.
7
Updated guidelines on the preoperative staging of thyroid cancer.甲状腺癌术前分期的更新指南。
Ultrasonography. 2017 Oct;36(4):292-299. doi: 10.14366/usg.17023. Epub 2017 Apr 9.
8
Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up.非间变性滤泡细胞源性甲状腺癌:长期随访中的有丝分裂和坏死
Eur Arch Otorhinolaryngol. 2017 Jun;274(6):2541-2548. doi: 10.1007/s00405-017-4527-6. Epub 2017 Mar 14.
9
Prognostic impact of extrathyroid extension and clinical lymph node metastasis in papillary thyroid carcinoma depend on carcinoma size.甲状腺外侵犯和临床淋巴结转移对甲状腺乳头状癌的预后影响取决于癌灶大小。
World J Surg. 2010 Dec;34(12):3007-14. doi: 10.1007/s00268-010-0776-x.
10
Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report.甲状腺乳头状癌中央区淋巴结转移数量的临床意义:初步报告
World J Surg. 2010 Nov;34(11):2558-63. doi: 10.1007/s00268-010-0749-0.